3 completed, 3 unknown. 4 Phase 1, 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
Follow FB2001: new trials by email Literature Review of FB2001 trials Research Report on FB2001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 FB2001, FB2001 placebo - Mild to Moderate COVID-19 | Phase 2 / Phase 3 | Unknown | Frontier Biotechnologies Inc. | 1336 | 2023-01-04 | 2023-01-09 |
| A Study of FB2001 for Inhalation in Healthy Chinese Adults FB2001 for inhalation, FB2001 for inhalation placebo - COVID-19 Pandemic | Phase 1 | Completed | Frontier Biotechnologies Inc. | 32 | 2022-10-21 | 2023-01-11 |
| Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study) FB2001, FB2001 placebo - COVID-19 | Phase 2 / Phase 3 | Unknown | Frontier Biotechnologies Inc. | 1188 | 2022-09-14 | 2023-01-05 |
| Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts FB2001 - Close Contact Transmission | Phase 1 / Phase 2 | Unknown | Ruijin Hospital | 60 | 2022-06-09 | 2022-06-13 |
| A Bridging Study of FB2001 in Healthy Subjects FB2001, FB2001 placebo - COVID-19 | Phase 1 | Completed | Frontier Biotechnologies Inc. | 40 | 2021-12-29 | 2022-07-06 |
| The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection FB2001, FB2001 Placebo - Covid19 | Phase 1 | Completed | Frontier Biotechnologies Inc. | 88 | 2021-03-17 | 2022-11-28 |
COVID-19 (4) · Coronavirus Infections (1)
Frontier Biotechnologies Inc. (5) · Ruijin Hospital (1)
China (4) · United States (1)
Cheng Yao (3) · Xin Li, PhD (1) · Yun Liu (1)